• News
  • SAN DIEGO
  • BioTech

Vista Partners updates coverage on Mast Therapeutics, maintains price target

San Francisco-based Vista Partners has updated coverage on Mast Therapeutics Inc., a San Diego-based biopharmaceutical company, and maintains its 12-month price target of $2.25.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Mast Therapeutics Inc.

Company Website

12390 El Camino Real Ste., 150
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
MSTX
0.56
  -0.02  
- 3.45%
1,176,743,000
1.10
0.40

Mast Therapeutics Inc. Executive(s):

Brian Culley

  • Chief Executive Officer

Patrick Keran

  • Chief Operating Officer, President

Brandi Roberts

  • Chief Financial Officer
Subscribe Today!